2009 ROCKY MOUNTAIN NASA SPACE GRANT CONSORTIUM

1

A R EEMERGENCE D EVICE FOR THE P OSTANESTHESIA C ARE U NIT
Cameron Jacobson
Department of Bioengineering, University of Utah, Salt Lake City, UT

Abstract—Hypercapnia is frequently used to accelerate
emergence from anesthesia in the OR, but not in the post
anesthesia care unit (PACU). To this end, a reemergence
device has been proposed that will take advantage of
hypercapnia to reduce recovery time and number of adverse clinical events experienced in the PACU. Interestingly
enough, little has been reported concerning the respiration
parameters (i.e CO2 , O2 , and anesthetic levels as well as
tidal volume and minute volume) experienced by patients
in the PACU. In order to determine the design criteria
for such a device, we need to collect data regarding a
patient’s status in the PACU. It is our hope to design a
device similar to the QED-100 (Anecare, Salt Lake City,
UT), that is small, mobile, versatile, and easy to operate
so that it can be used in a wide variety of situations. This
paper discusses the steps and system being designed to
collect this data as a foundation for this work.

I NTRODUCTION

T

HE cardiovascular and respiratory systems work
in tandem to provide the necessary gas exchange
for cellular metabolic activity throughout the body. The
respiratory system exchanges O2 and CO2 between the
atmosphere and blood; the circulatory system delivers the
O2 to cells throughout the body and transports CO2 —a
byproduct of cellular respiration—from the cells back to
the lungs. When CO2 levels fluctuate, the cardiovascular
and respiration systems are adjusted to compensate.
For example, if the arterial partial pressure of CO2
(P aCO2 ) rises, respiration will increase and vasodilation
will occur, increasing blood flow and gas exchange in
order to flush the body of excess CO2 . When P aCO2 is
reduced, the opposite occurs. In the OR, this principle
is frequently taken advantage of to aid patients during
recovery from anesthesia.
Anesthetic vapors can be removed in the same way
that excess CO2 is flushed from the body. In this way,
induced hypercapnia or elevated P aCO2 can be used
to accelerate a patient’s recovery from anesthesia[1],
[2]. A device developed in our lab called the QED100 (Anecare, Salt Lake City, UT) is a device that
accomplishes this task during the emergence phase of
anesthesia in the OR (Figure 1)[3]. This device incorporates a rebreathing reservoir to induce hypercapnia
and a charcoal filter to soak up expelled anesthetic

Fig. 1.
The QED-100 device used to induce hypercapnia in
patients immediately following surgery. A rebreathing hose elevates
CO2 levels while a charcoal filter soaks up expelled anesthetic gas.
(www.anecare.com)

gases. Studies have shown that the QED-100 is capable
of reducing emergence times by approximately 55%;
however this device is only used in the OR until the
patient is conscious and able to maintain a patent airway
and then they are transported to the PACU to continue
recovery until hospital discharge criteria are met[3], [4],
[5].
The incidence of adverse clinical events is much
higher in the PACU than the OR. Studies have shown
that of 42,000 patients monitored, 23–24% experienced
complications in the PACU, while only 3.8–5.1% encountered difficulties in the operating room[6], [7], [8].
As a patient becomes more alert in the PACU, a greater
awareness of pain is attained, resulting in the administration of additional analgesics, which can react synergistically with trace amounts of anesthetic and induce any
number of adverse clinical events, including difficulties
breathing and even loss of consciousness.
To help remedy this situation, a device has been
proposed for use in the PACU that will take advantage
of hypercapnia in order to reduce recovery time and the
number and severity of adverse clinical events. The goal
is to integrate the functionality of the QED-100 with a
standard oxygen mask with which patients and hospital
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staff are already familiar; however, the design criteria
for such a device is quite different from those used for
the QED-100. In contrast to the OR where ventilation
is performed and monitored closely by an anesthesia
machine, a patient in the PACU is conscious and breathing on their own—albeit an irregular, shallow, and slow
breathing pattern due to sub-anesthetic levels of drug still
present in their body. In this state they are at greater risk
of hypoxia, and often supplemental oxygen is given to
compensate. The use of a hypercapnia-inducing device,
like the QED-100, in this setting would further increase
the risk of hypoxia. Therefore, the design criteria must
include a way to maintain adequate oxygenation while
still inducing hypercapnia.
Two methods have been considered to accomplish
this task: a modified oxygen mask that incorporates the
function of the QED-100, including a rebreathing hose
and charcoal filter with a port for supplemental oxygen;
or a standard oxygen mask supplied with a mixture of O2
and CO2 . Both have their advantages and disadvantages.
The rebreathing mask makes use of the available CO2
that the patient produces, but the simple addition of an
oxygen port to the mask may dilute the rebreathed air
sufficiently as to diminish or even cancel the hypercapnic
effect of rebreathing. Also, the rebreathing hose and
charcoal filter add bulk to the mask, which may make it
cumbersome. The standard mask with a mixture of O2
and CO2 requires nothing extra in way of the mask,
but does require additional equipment to supply the
mixture of gases. In either case, determining the optimal
gas mixture to induce hypercapnia for a patient with
an irregular breathing pattern is difficult because CO2 ,
minute volume, and even anesthetic levels are typically
not monitored in the PACU, like they are in the OR, and
very little information has been published regarding these
parameters in the PACU. Hence, the first step towards
designing a hypercapnia-inducing device for the PACU
is to understand the relevant respiratory parameters encountered in the PACU. This paper addresses the work
currently being done to obtain this information.
M ONITORS
We will collect information from patients recovering
from anesthesia in the PACU. Two monitors will be
used: the Capnomac Ultima (Datex, Helsinki, Finland)
and Respitrace Calibrator (Ambulatory Monitoring, Inc.,
Ardsley, NY). The Capnomac Ultima is capable of
measuring CO2 , O2 , and anesthetic levels as well as tidal
volume, and minute volume. To obtain accurate volume
measurements, the patient must wear a tight fitting mask,
and unfortunately many patients are irritated by even the
loose fitting oxygen mask presently used in the PACU.

Also, supplemental oxygen will most likely be given to
the patient during this process, which will interfere with
the volume measurements. The Respitrace monitor is an
alternative approach to measuring volume.
The Respitrace monitor provides a method of measuring tidal volume and minute volume without using
a mask. It measures the expansion of the chest and
abdomen due to breathing using impedance readings
from special bands placed around the patient, which
should be tolerable since they are laying down and
moving very little. The impedance reading can then be
calibrated to produce volumetric information.
With this configuration the tidal volume and minute
volume will be measured using the Respitrace and the
CO2 , O2 , and anesthetic levels will be measured using
the Capnomac Ultima through a nasal cannula, which
patients generally tolerate better than the mask.
Another advantage of using the Respitrace for volumetric measurements is that the patient can be tested
with other breathing devices, like a mask with a mixture
of CO2 and O2 gases, as mentioned, or a rebreathing
device like the QED-100, without interferring with the
flow measurement.
Custom software is being developed to integrate the
two monitors into one system that will sample and record
relevant information from both monitors simulaneously.
Both monitors have analog outputs that can be sampled
using the USB-1208LS analog-to-digital converter (Measurement Computing, Middleboro, MA). To calibrate the
Respitrace, the patient must breath into a sealed mask
for 30 s so that flow data can be recorded using the
Capnomac Ultima. Once the Respitrace is calibrated
the mask will be replaced with a nasal cannula and
monitoring will begin.
S OFTWARE
Figure 2(a) shows a screenshot of the software with
the raw waveforms from the Capnomac Ultima and
Respitrace displayed. This screen allows the user to
validate that the system is collecting data and working
properly. The green waveform is from the Respitrace,
which is a sum of the impedance readings from the
chest and abdomen bands. The red is CO2 , the white is
O2 , the pink is anesthetic, the yellow is volume, and the
blue is flow. The pulses seen at the peak of the volume
waveform are flags that the Capnomac Ultima generates
to signal the beginning of a new breath.
Figure 2(b) shows a screenshot of the calibration
screen: the red waveform is from the Capnomac Ultima,
the green is from the Respitrace. In order to view
and record the tidal volume and minute volume using
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Fig. 2. Screenshot of the software written to integrate the Capnomac Ultima and Respitrace into one system to monitor patients recovering
in the PACU. (a) Raw waveforms of Capnomac Ultima and Respitrace. (b) Calibration screen where green is the Respitrace and red is the
Capnomac.

the Respitrace data, an algorithm is currently being
developed to analyze the calibrated volumetric waveform
in real-time to determine the tidal volume and minute
volume.
The next step in development will be to test and verify
the workflow of this system so that data can be collected
easily and consistently in the PACU.

C ONCLUSIONS
The data collected in the PACU regarding a patient’s
respiratory parameters will be of great interest since little
has been published concerning this aspect of recovery
from anesthesia, especially in light of the higher risk
of adverse clinical events that can occur in the PACU.
Using this data as a foundation, we can gain a better
understanding of how a patient recovers in the PACU.
This data will also serve to validate a numerical model
and bench test model that have already been developed,
showing the interaction between rebreathing and supplemental O2 . Given the data and models, we hope to
develop a device that takes advantage of hypercapnia
while providing adequate oxygenation in order to accelerate and make safer the recovery from anesthesia in the
PACU.

ACKNOWLEDGMENTS
The author would like to thank Dr. Dwayne Westenskow and Dr. Joseph Orr for their involvement and
direction in this project.

R EFERENCES
[1] D. J. Sakata, N. A. Gopalakrishnan, J. A. Orr, J. L. White,
and D. R. Westenskow, “Hypercapnic hyperventilation shortens
emergence time from isoflurane anesthesia.” Anesth Analg, vol.
104, no. 3, pp. 587–591, 2007.
[2] ——, “Rapid recovery from sevoflurane and desflurane with
hypercapnia and hyperventilation.” Anesth Analg, vol. 105, no. 1,
pp. 79–82, 2007.
[3] R. R. Blocker, D. J. Sakata, N. A. Gopalakrishnan, J. A. Orr,
and D. R. Westenskow, “Clinical evaluation of the qed-100
emergence device,” Anesthesiology, vol. 105, no. A853, 2006.
[4] D. J. Sakata, N. Gopalakrishnan, J. A. Orr, and J. White, “Clinical
evaluation of a device to speed emergence from sevoflurane
anesthesia,” Anesthesiology, vol. 103, p. A796, 2005.
[5] D. Sakata, J. Orr, and D. Westenskow, “Evaluation of a device
to speed emergence from inhaled anesthetic,” Anesthesiology,
vol. 99, p. A576, 2003.
[6] R. Hines, P. G. Barash, G. Watrous, and T. O’Connor, “Complications occurring in the postanesthesia care unit: a survey.”
Anesth Analg, vol. 74, no. 4, pp. 503–509, 1992.
[7] D. K. Rose, M. M. Cohen, D. F. Wigglesworth, and D. P.
DeBoer, “Critical respiratory events in the postanesthesia care
unit. patient, surgical, and anesthetic factors.” Anesthesiology,
vol. 81, no. 2, pp. 410–418, 1994.
[8] C. Mamie, W. Habre, C. Delhumeau, C. B. Argiroffo, and
A. Morabia, “Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery.”
Paediatr Anaesth, vol. 14, no. 3, pp. 218–224, 2004.

